1) β1 antagonist
β1受体阻滞剂
1.
Effect of β1 antagonist on the cardiac hemodynamics of rats with acute left heart failure;
β1受体阻滞剂对急性左心衰大鼠血流动力学的影响
2) β1-blocker
β1-受体阻滞药
3) The-blocker
受体阻滞剂
1.
The-blocker acts different according to its different chemical structure,its application is more wider,especially the application in cardiovascular diseases.
受体阻滞剂根据其化学结构不同,其应用也不同,特别是在心血管病中的应用,越来越广泛。
4) a-adrenoreceptor blocker
a受体阻滞剂
1.
Objiective:To observe the impact of a-adrenoreceptor blocker of rabbit renal pelvis pressure of obstruction.
目的:观察a受体阻滞剂对梗阻后兔肾盂压力的影响。
5) β-blocker
β-受体阻滞剂
1.
Application of β-blockers to the therapy of heart failure and the problems;
β-受体阻滞剂在心力衰竭治疗中的应用及存在问题
2.
The Effects of β-blocker on the Maximum P Wave Duration(Pmax)and P Wave Dispersion(Pd) in Hypertension Patients with Paroxysmal Atrial Fibrillation;
β-受体阻滞剂对高血压伴阵发性房颤患者P波离散度及P波最长时限的影响
3.
The effect of β-blocker on Pmax and Pd in chronic cardiac insufficiency patients with paroxysmal atrial fibrillation;
β-受体阻滞剂对老年慢性心力衰竭伴阵发性房颤患者P波最大时限及P波离散度的影响
6) α-blocker
α-受体阻滞剂
1.
By analyzing the interaction of phosphodiesterase type 5 inhibitor (PDE5i) and α-blocker for treating benign prostate hyperplasia(BPH) and erectile dysfunction(ED), useful suggestions have been brought up to decrease adverse reactions of combined treatment of α-blocker and PDE5i.
通过综述磷酸二酯酶5型抑制剂与α-受体阻滞剂的相互作用以及联合用药治疗前列腺增生合并勃起功能障碍的临床安全性和有效性,为减少磷酸二酯酶5型抑制剂联合应用α-受体阻滞剂的不良反应提供借鉴。
2.
Methods 42 cases of CP/CPPS who coincidence with New NIH consensus definition and classification of prostatitis, were treated with α-blocker add biofeedback physical therapy.
目的探讨Α-受体阻滞剂加生物反馈疗法联合治疗Ⅲ B型慢性前列腺炎,慢性盆底疼痛综合征(CP／ CPPS)的疗效。
补充资料：受体阻滞剂
受体阻滞剂
receptor blocking agen?ts
能与受体结合，但并不激动受体，而同时又能阻止该受体激动剂与结合的药物。例如阿托品可与M胆碱受体结合，但不激动M受体，同时又能阻止M受体激动剂乙酰胆碱与M受体结合，从而表现抗乙酰胆碱的药理作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条